Related Experiment Video
Updated: Jul 29, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to
G Senaldi1, M Peakman, T McManus
1Department of Immunology, King's College School of Medicine and Dentistry, London, United Kingdom.
Insights
Complement pathway activation is linked to human immunodeficiency virus (HIV) disease progression. Increased classical complement pathway activation correlates with worsening HIV infection markers and declining CD4+ lymphocyte counts.
Area of Science:
- Immunology
- Virology
Background:
- In vitro studies suggest complement pathway activation contributes to human immunodeficiency virus (HIV) pathogenesis.
- The in vivo relevance of classical and alternative complement pathways in HIV infection requires further investigation.
Purpose of the Study:
- To evaluate the in vivo significance of complement pathway activation in HIV-infected individuals.
- To correlate complement activation markers with disease progression and immune status.
Main Methods:
- Measured classical (C4d), alternative (Ba), and common (C3d) complement pathway activation fragments and ratios in 74 HIV-infected patients.
- Related fragment levels to circulating immune complex (CIC) levels, Centers for Disease Control (CDC) stage, beta 2-microglobulin, neopterin, and CD4+ lymphocyte counts.
Main Results:
- All measured complement fragments and ratios were significantly elevated in HIV patients compared to controls.
- Classical pathway activation indices (C4d, C4d to C4) increased with disease severity (CDC stage) and correlated with elevated CIC and beta 2-microglobulin.
- Classical pathway activation correlated inversely with CD4+ lymphocyte counts, indicating a link to immune decline.
Conclusions:
- In vivo complement pathway activation, particularly the classical pathway, is significantly associated with HIV infection.
- Classical complement pathway activation appears to play a role in HIV disease progression and immune deterioration.
Abstract:
In vitro studies implicate classical and alternative complement pathway activation in the pathogenesis of human immunodeficiency virus (HIV) infection. To ascertain their importance in vivo, activation fragments of the classical (C4d), alternative (Ba), and common (C3d) pathways were measured and fragment to parent molecule ratios derived in 74 HIV-infected individuals and related to circulating immune complex (CIC) levels, Centers for Disease Control (CDC) stage, and beta 2-microglobulin, neopterin, and CD4-positive (CD4+) lymphocyte levels. All fragments and ratios were significantly higher in patients (P less than .01) than controls. C4 conversion indices (C4d and C4d to C4) increased linearly with increasing CDC stage (P less than .001), while CD4+ lymphocytes decreased linearly (P less than .001). C4d, C3d, C4d to C4, and C3d to C3 correlated with increasing CIC and beta 2-microglobulin, and C4d and C4d to C4 correlated with decreasing CD4+ lymphocytes (P less than .05). The relationship of classical complement pathway activation to disease progression and CD4+ lymphocytes suggests its involvement in the pathogenesis of HIV infection.
More Related Videos
Related Concept Videos
Humoral Immune Responses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Complement System
Cryptococcal Meningitis
Inhibitors of Virion Maturation and Assembly

